Skip to main content
PMC home page
Scientific Reports logoLink to Scientific Reports
. 2020 Dec 9;10:21579. doi: 10.1038/s41598-020-78176-7

Engineering pericyte-supported microvascular capillaries in cell-laden hydrogels using stem cells from the bone marrow, dental pulp and dental apical papilla

S Prakash Parthiban 1, Wenting He 1, Nelson Monteiro 1, Avathamsa Athirasala 2, Cristiane Miranda França 1, Luiz E Bertassoni 1,2,3,4,✉
PMCID: PMC7726569  PMID: 33299005

Abstract

Engineered tissue constructs require the fabrication of highly perfusable and mature vascular networks for effective repair and regeneration. In tissue engineering, stem cells are widely employed to create mature vascularized tissues in vitro. Pericytes are key to the maturity of these vascular networks, and therefore the ability of stem cells to differentiate into pericyte-like lineages should be understood. To date, there is limited information regarding the ability of stem cells from the different tissue sources to differentiate into pericytes and form microvascular capillaries in vitro. Therefore, here we tested the ability of the stem cells derived from bone marrow (BMSC), dental pulp (DPSC) and dental apical papilla (SCAP) to engineer pericyte-supported vascular capillaries when encapsulated along with human umbilical vein endothelial cells (HUVECs) in gelatin methacrylate (GelMA) hydrogel. Our results show that the pericyte differentiation capacity of BMSC was greater with high expression of α-SMA and NG2 positive cells. DPSC had α-SMA positive cells but showed very few NG2 positive cells. Further, SCAP cells were positive for α-SMA while they completely lacked NG2 positive cells. We found the pericyte differentiation ability of these stem cells to be different, and this significantly affected the vasculogenic ability and quality of the vessel networks. In summary, we conclude that, among stem cells from different craniofacial regions, BMSCs appear more suitable for engineering of mature vascularized networks than DPSCs or SCAPs.

Subject terms: Biotechnology, Tissue engineering

Introduction

The human vasculature is a vital component of any cellularized tissue in the body. Blood vessels and capillaries supply all cells with oxygen, nutrients, and paracrine signals for efficient tissue growth and homeostasis. Therefore, a critical hallmark of any engineered tissue is that, after implantation, it should be supplied with sufficient blood to avoid ischemia, hypoxia, and necrosis1. Vascular tissue engineering addresses these problems by facilitating the fabrication of engineered tissues with a functional vascular system that is able to replicate the circulatory and biological role of the host vasculature2–5. However, understanding and controlling the complex heterotypic interactions that are required to establish a functional vasculature in engineered tissues remains a challenge. Much has been learned about the process of endothelial cell morphogenesis during angiogenesis and vasculogenesis, both during tissue development and remodeling5–8. However, control over the myriad interactions occurring between endothelial cells and other mural cells that contribute to the formation of functional vascular capillaries remains poorly understood.

One of the key components of the native vasculature are perivascular mural cells that surround the endothelial lining of the peripheral microvasculature9–11. Endothelial cells and pericytes complement each other during  blood vessel formation, with endothelial cells lining the interior of the tubule wall, whereas pericytes cover the exterior of the vascular tube providing vessel stabilization, barrier function, regulation of blood flow, and immune regulation12–18. Typically, pericytes are surrounded by a basement membrane, and present an archetypal morphology ranging from spindle to stellate across the microvascular tree19. Functional vascular capillaries stabilize pericytes by maintaining the integrity of cell–cell junction and synthesis of the extracellular matrix (ECM) in the basement membrane. Therefore, these cells are largely recognized for being necessary for proper functioning of the small blood vessels15. In the absence of pericytes, a dysfunctional microvasculature is established, presenting hemorrhagic and hyper dilated capillaries that can lead to conditions such as hypertension, diabetes, edema, and embryonic lethality20. Therefore, the establishment of functional pericytes into vascularized biomaterials is a desirable step for repair and regeneration of highly cellularized tissues.

It has long been known that pericytes derive from the differentiation of stem cells from the mesenchyme in various tissues21. However, the inherent ability of stem cells from different sources to differentiate into pericytes during the formation of vascular capillaries remains poorly understood, especially in the context of craniofacial and dental regeneration, where repair and healing often involves tissues and structures that are inherently highly vascularized, such as the skeletal muscle, bone and the dental pulp. Several reports have demonstrated the ability of stem cells from different origins to differentiate into pericytes22–24. In fact, a recent systematic review evaluated 20 publications reporting on the differentiation of stem cells into pericytes, and concluded that these cells can serve as a potential source of pericytes with varying potential. However, there is limited information available in the literature to directly compare stem cells from different tissue sources with respect to their ability to form pericyte-supported vascular capillaries for tissue engineering25. To address this limitation, here we compared stem cells isolated from different craniofacial tissues, and analyzed their ability to differentiate into pericytes and to form microvascular capillaries, both when seeded in two-dimensional (2D) substrates, as well as embedded in three-dimensional (3D) cell-laden biomaterials. We hypothesized that stem cells from different craniofacial regions would result in significantly different vasculogenic patterns and pericyte-differentiation ability. Due to their ease of availability and sourcing as well as their ubiquity in cell based regenerative applications, we chose to study bone marrow mesenchymal stem cells (BMSC) and investigate their potential to differentiate into pericyte like cells26. We compared their behavior with those of two other stem cell types that can be easily harvested from healthy extracted teeth, such as third molars, namely stem cells from the apical papilla (SCAP) and dental pulp stem cells (DPSC). These represent easily accessible and expandable stem cell sources, with proven regenerative potential, thereby making them ideal candidates for tissue engineering applications27,28. To that end, we cultured these stem cells either individually or in co-culture with human umbilical vein endothelial cells (HUVEC) in gelatin methacrylate (GelMA) hydrogels. Our results demonstrate that the ability of stem cells to differentiate into a perivascular lineage when co-cultured with HUVECs is significantly distinct depending on the tissue source. Moreover, stem cells from different tissue types show a significant difference of trophic effects on the vasculogenic ability of endothelial cells in cell-laden hydrogels.

Results

Figure 1 shows stem cells from bone marrow (BMSC), apical papilla (SCAP) and dental pulp (DPSC), either alone or in co-culture with HUVECs, on 2D GelMA hydrogels. For 2D experiments, we chose to use the late stage marker, α-SMA for pericyte identification. All the cells did not show pericyte differentiation when cultured alone on GelMA hydrogel, while co-culture with HUVECs, all groups showed a marked differentiation potential among the stem cells. BMSCs had a better differentiation ability than the other stem cells. The morphology of the differentiated cells in all the stem cell systems looked nearly identical, with some cells showing extended processes, bearing in mind that the 2D substrate affect the way that cells spread and communicate with endothelial cells. The fraction of α-SMA positive cells with BMSC was 2.5 times higher when compared to SCAP (p < 0.0001), and 1.6 times higher compared to DPSC (p < 0.0001) (Fig. 2). Next, we evaluated the behavior of stem cells in 3D by encapsulating them in GelMA hydrogels.

Figure 1.

Figure 1

Open in a new tab

(A, C, E) Stem cells seeded onto GelMA hydrogels (2D) without HUVECs showed no expression of α SMA. (B, D, F) When co-cultured with HUVECs, stem cells from all three sources showed visible expression of the pericyte-related marker α-SMA, thus suggesting their consistent differentiation.

Figure 2.

Figure 2

Open in a new tab

Quantification of α-SMA positive cells on GelMA hydrogels. The untreated groups are the monocultured stem cells without HUVECs, i.e., the BMSC, SCAP and DPSC. The untreated groups hardly expressed any α SMA positive cells. However, when cocultured with HUVECs, the stem cells differentiated to express α-SMA. The number of α-SMA positive cells was higher in BMSC system followed by DPSC and SCAP cells. (****p < 0.0001).

The main goal of Fig. 3 was to demonstrate the efficacy of the differentiation of the craniofacial tissue-derived stem cells into pericytes, in conditions that may more closely approximate clinical applications. On that note, important results have recently demonstrated the regeneration of vascularized dental pulp, alveolar bone and periodontal tissue using cell-laden hydrogels co-cultured with different lineages of endothelial and stem cells29–32, such as the ones used here. However, it remains unclear whether the cross comparison of different stem cells can result in better differentiation and vasculogenic ability. Figure 3 shows the formation of microvascular networks after days 5 and 7 of culture. All stem cell types formed vascular networks around day 5, and continued to stabilize around day 7. A marked feature that stood out for DPSC and SCAP were the presence of cluster of cells along with the vascular networks.

Figure 3.

Figure 3

Open in a new tab

(A, D, G) DPSC-HUVECs, (B, E, H) BMSC-HUVECs, and (C, F, I) SCAP-HUVECs formed vascular networks. BMSC-HUVECs formed dense vascular networks by day 5 (E). After the pericyte formation, BMSC system remained the same (F), however, the DPSC (G) and SCAP (I) showed cell island formation along with vascular networks.

This feature was markedly missing in BMSC-laden samples. Regarding the specific vascular network parameters (Fig. 4), the average vessel length was higher for SCAPs on day 5, however, it drastically decreased by sevenfold on day 7 (p < 0.0001). The average vessel length of DPSC and BMSCs remained statistically unchanged over the 7 day period. The total vessel length of SCAP showed the same trend, as it dropped sixfold from day 5 to day 7 (p < 0.0001). The total vessel length of DPSC and BMSC groups also decreased 1.8-fold from day 5 to day 7 (p < 0.002 and p < 0.0002 respectively). The vessel percent area is a parameter which measures the total area covered by the vessels divided by the total image area. The vessel coverage for SCAP system decreased eightfold from day 5 to day 7 (p < 0.0001). This effectively signals the role of pericytes in the decrease of the coverage area. Similarly, the branching index of SCAP on day 7 decreased approximately tenfold when compared to day 5 (p < 0.0002). All these vascular parameters denote one common thing, a considerable reduction of vascular network parameters on day 7.

Figure 4.

Figure 4

Open in a new tab

Vascular network quantification of the encapsulated stem cells-HUVECs in GelMA hydrogel. The vascular network parameters, namely, (A) total vessel length, (B) average vessel length, (C) vessel percent area, and (D) branching index showed a marked decrease from day 5 to day 7 owing to the effect of pericytes.

It is well known that upon differentiation, stem cells have a tendency to line along the vasculature by extending their processes22. With respect to the stem cells, SCAP showed a considerable reduction in all vasculature parameters on day 7. From these results, it can be concluded that SCAP cells forms a less attractive stem cell source to engineer mature vascular systems when cultured in vitro than other stem cells. Figure 5 shows the immunofluorescence staining for α-SMA and NG2 after seven days of culture.

Figure 5.

Figure 5

Open in a new tab

Early marker (NG2) and late marker (α-SMA) staining of differentiated stem cells. While BMSC showed the distribution of both cells (A, B), the DPSC (C, D) and SCAP (E, F) showed marked absence of NG2 positive cells.

As expected, α-SMA was highly expressed in differentiated BMSCs followed by DPSCs and SCAP. Another marker, NG2 showed a similar trend, but very less cells showed NG2 expression for DPSC and SCAPs. For SCAPs, there was hardly any NG2-expressing cells, which showed expression of NG2 is vastly different among stem cells of different source (Fig. 6).

Figure 6.

Figure 6

Open in a new tab

Early marker (NG2) and late marker (α-SMA) staining of differentiated stem cells with pericyte inducer TGF-β. The effect was identical with that of stem cell system involving no TGF-β. The BMSC showed the distribution of both cells (A, B), while DPSC (C, D) and SCAP (E, F) showed marked absence of NG2 positive cells.

Because ⍺-SMA was the most expressed marker for differentiated cells, we quantified the number of using ⍺-SMA positive cells in all groups using ImageJ. A fraction of 60% of BMSC expressed ⍺-SMA when co-cultured with HUVECs, while for DPSC, around 45% of cells were positive for this marker. SCAP had the least expression of ⍺-SMA with only 30% of cells being positive for the marker (Fig. 7).

Figure 7.

Figure 7

Open in a new tab

Quantification of late marker (α-SMA) staining of differentiated stem cells with and without pericyte inducer TGF-β. The effect was similar with that of stem cell system involving no TGF-β. BMSC expressed more (α-SMA), followed by DPSC and SCAP (two-way ANOVA, post hoc Tukey, p > 0.05).

Interestingly TGF-β supplementation of the cell medium did not seem to promote an increased expression of ⍺-SMA (two-way ANOVA, post hoc Tukey, p > 0.05).

Discussion

The primary goal of this study was to determine the ability of different stem cells from tissues in the craniofacial region (BMSC, DPSC, and SCAP) to differentiate into pericytes and form robust microvascular capillary networks in engineered hydrogels. Our results suggest that BMSCs are significantly more potent in promoting the formation of microvascular capillaries in co-cultures with HUVECs than DPSCs or SCAP. Also, BMSCs appeared more prone to expressing higher levels of pericyte-related markers, such as α-SMA and NG2 when establishing microvascular capillaries in cell-laden hydrogels.

The most suitable cell sources for tissue engineering are cells that can be easily harvested, have high proliferative rates, are nonimmunogenic, and possess multiple-lineage differentiation capacity33. Therefore, stem cells have long been proposed as a desirable alternative to engineer mature vascular capillaries together with endothelial cells. Several reports have demonstrated the use of BMSCs to engineer vascular capillaries, including a few of our own29,33–35. Similarly, stem cells from various other sources, such as adipose-derived, induced pluripotent, embryonic, neural stem cells have also been tested for their pericyte differentiation ability25. However, direct comparisons between stem cells from easily accessible tissues, such as the bone marrow and extracted teeth, have remained elusive in the literature. Moreover, the use of craniofacial derived stem cells has been proposed as a desirable alternative for specific applications in regenerative dentistry and craniofacial reconstruction, and to date, information on improved candidates for craniofacial vascular engineering have remained limited27,28,36,37. Pericytes play a vital role in the maturation and functionality of microvascular networks by maintaining the integrity of cell–cell junction, and synthesis of the extracellular matrix (ECM) of the basement membrane38. Hence, the need to integrate pericytes in engineered vasculature is vital as it closely mimics the physiological functions39. For our study, we used early-passage cells (P4-8) considering the “stemness” window accepted by the literature. SCAP can be expanded up to 20 passages still keeping expression of stem cell markers CD73, CD90 and CD10560. Conversely, BMSC largely lose their in vitro differentiation capability around the 6th passage61 and DPSCs from passage 9 on show a decrease in their proliferative capacity and upregulation of genes such as alkaline phosphatase, dentin sialophosphoprotein and osteopontin, related to differentiation into a mineralizing cell phenotype62. Interestingly, we observed that although SCAP could keep their stemness for longer, their potential to differentiate into pericytes was lower than that of DPSC.

The first observation that requires attention in the comparison of stem cells alone versus co-cultures of stem cells and endothelial cells is that HUVECs appeared to be critically required to induce the differentiation of all three stem cell types in pericytes when seeded in 2D substrates, despite the use of the exact same medium conditions. This is a relevant observation, as it alludes to the ability of paracrine signals secreted from ECs to promote pericyte differentiation despite the absence of exogenous growth factors, which is typical in the field of regenerative medicine40,41. Cell–cell contact between BMSCs and endothelial cells has been shown to induce pericyte-like cell differentiation with upregulation of pericyte markers like CD146, NG2, and α-SMA42. Transforming growth factor-beta (TGF-β) and Notch signaling mediate stem cell differentiation to pericytes and smooth muscle cells43. In particular, the TGF-β family has been involved in regulating vascular development and barrier function44. When cultured, HUVECs will produce growth factors such as TGF-β and basic fibroblast growth factor45. To gain further insights into this particular phenomenon, we performed additional experiments using TGF-β (a commonly reported inducer of pericyte differentiation in the literature) in our medium as a positive control, and observed comparable results to those obtained with a co-culture of HUVECs and stem cells without any additives (Fig. 6). Upon the observation that all three stem cell types were capable of inducing the expression of a pericyte-related marker (α-SMA) without using TGF-β in the medium, we engineered hydrogels using a dental curing light, which we have demonstrated to be compatible with engineering of dental pulp-like tissue46 and vascular capillaries directly in root canals47. Our results demonstrated that similar to our 2D cell culture screening, BMSC were visually more capable of stimulating well-established microvascular capillary networks (Fig. 3). A similar observation was made with the 3D cell culture, where a reduction in vascular parameters after 5 days of culture was seen (Fig. 4). Usually, pericyte differentiation takes approximately 5 days, so the reduction in the average vessel length can be attributed to effect of conjoining of pericytes to capillaries40,41,48. The decrease in vasculature parameters can be attributed to the constrictory nature of the pericytes. α-smooth muscle actin (α-SMA) is conventionally used by pericytes to constrict capillaries49,50. Given that all the differentiated stem cells extensively express α-SMA, this effect may lead to constriction leading to the vessel shrinkage length and area51. This explains the overall behavior of the decrease in vasculature parameters in some of the stem cell we utilized. Of note, not only BMSCs formed vascular capillaries sooner than SCAP, but also, they appeared to resist against vascular regress more clearly than DPSCs, which were quantitatively comparable to BMSCs in the quantification of vasculature formation.

The main challenge while dealing with identification of pericytes is the lack of a single definitive marker to identify pericytes. NG2, Desmin, α-SMA, and PDGFRβ are some of the markers used in the field to identify pericytes52. NG2 chondroitin sulfate proteoglycan is a structurally unique, integral membrane proteoglycan expressed in several types of immature cells, and by mural cells during vascular morphogenesis53. Therefore, to further confirm the differentiation of stem cells into pericytes and elucidate the specificity of the perivascular phenotype adopted by these cells, in addition to α-SMA, we also characterized the expression of NG2 for cell co-cultured with HUVECs in our engineered hydrogels. Of note, NG2 also represents the early stage marker of pericytes, while α-SMA is considered a late stage protein in the differentiation process40,54. Thus, these markers may not only indicate the maturity of the pericyte cells but also can give an idea about the phenotype which the pericytes can take in the microvascular tree. Moreover, it is well known that pericytes adopt different morphologies along the microvascular bed, and similar to their morphologies, the expression of pericyte markers also continues to vary55. For instance, NG2 is highly expressed in capillary pericytes, while it continues to decrease for pericytes on arterioles and venules54. On the contrary, α-SMA is expressed less in the capillary pericytes, but its expression increases for pericytes on arterioles and venules. In fact, with NG2 and α-SMA expression, one can distinguish the three subsets of human pericytes in the following way: capillaries (NG2 +  α-SMA-), venules (NG2-α-SMA +) and arterioles (NG2 + α-SMA +)14,56,57. In our results, both α-SMA and NG2 were expressed in BMSCs, whereas DPSC showed a higher expression of α-SMA positive cells than NG2 positive cells, and SCAP hardly showed any NG2 positive cells despite the consistent expression of α-SMA. Therefore, it appears as though BMSC can more easily adopt diverse pericyte-related phenotypes that are associated with mural cells covering of arterioles, capillaries, and venules, whereas DPSCs and SCAP may be slightly more tilted towards mural cells covering the arterioles and venules, and less on capillaries. This difference is possibly due to the location from which the stem cells are isolated. SCAPs are isolated from the root of a developing immature teeth, while the DPSCs are extracted from the inner tooth pulp of adult molars28,58. Further, it is well known that vasculature density differs in the root (apical area) and crown parts of the pulp59. Therefore, this might be the reason for the varied levels of marker expression among the stem cells.

In summary, our results point to important observations regarding the ability of stem cells from different craniofacial tissues to differentiate into pericytes and form microvascular capillary networks in engineered hydrogels. Accordingly, BMSC appear more suitable for engineering of pericyte-supported capillaries than DPSCs or SCAPs. We propose that these results may be useful to facilitate the repair and regeneration of craniofacial and dental tissues.

Methods

Cell culture

All experiments used green fluorescent protein (GFP)-expressing human umbilical vein endothelial cells (HUVECs—cAP0001GFP, Angioproteomie) (P5-10), which were cultured in Endothelial Growth Medium (EGM) (cAP-02, Angioproteomie) on gelatin (0.1% (w/v)) coated substrates. SCAP (P4-8) (primary cells donated by Dr. Diogenes, University of Texas), and DPSC (P4-8) (primary cells, catalog # PT-5025, Lonza, Basel, Switzerland) were cultured in alpha-MEM supplemented with L-glutamine, 10% (v/v) fetal bovine serum and 1% (v/v) penicillin–streptomycin. Primary cultures of bone marrow human mesenchymal stem cells (BMSC) (donated by Dr. Brian Johnstone, OHSU Orthopedics) on passages 3 and 4 were cultured in alpha-MEM supplemented with L-glutamine, 10% (v/v) fetal bovine serum and 1% (v/v) penicillin–streptomycin. All cells were maintained in an incubator at 37 °C, 5% CO2, with media replacement every 2 days.

Sample preparation

GelMA hydrogel precursor was synthesized by reacting gelatin with methacrylic anhydride according to previously established protocols60. GelMA hydrogels for 2D and 3D models were separately formulated to achieve the material properties that support endothelial monolayer formation and microcapillary network formation respectively29,46,61. Consequently, for the 2D assays, we used 10% (w/v) GelMA precursor, 0.05% (w/v) LAP in DPBS62, whereas the hydrogels for 3D experiments were formulated with 5% (w/v) GelMA precursor with 0.075% (w/v) LAP in DPBS63. GelMA hydrogel samples (9.2 mm diameter, 150 micron thick) were fabricated by dispensing 10 µl of the appropriate GelMA formulation on TMSPMA coated glass between 150 micron thick spacers and photopolymerizing with a dental curing light (Valo) for 5 s. For the pericyte differentiation assays in 2D, each stem cell line was seeded on to the surface of the hydrogel either alone or in co-culture with GFP-HUVECs (1:4) at a density of 75 cells/mm2 for 7 days in modified EGM. In order to fabricate 3D cell-laden constructs, a co-culture of GFP-HUVECs and stem cells were suspended in the hydrogel precursor in a 4:1 ratio at a density of 5 × 106 cells/ml prior to fabrication. All samples were cultured for a 7 day period. For positive control, 2 ng/mL TGF-β was added to the modified EGM medium.

Immunostaining

Prior to immunostaining, samples were fixed with 10% (v/v) formaldehyde and permeabilized using 0.1% (v/v) Triton X-100. They were then blocked with 1.5% (w/v) bovine serum albumin (Sigma Aldrich) in DPBS for 1 h, following which they were treated with Image-iT FX signal enhancer (Invitrogen, CA) for 30 min. Samples were then immunostained with antibodies against α SMA (0.4 µg/ml) (Thermofisher Scientific, # MA5-11547) and NG2 (R&D systems, #FAB25851R) and imaged using fluorescence microscopy. As a measure of the expression of α-SMA, the intensity of fluorescence signal from the antibody against α-SMA was quantified for all the cells in a sample using Image J software. The cells with fluorescent signal above that of the background were identified as α-SMA positive cells.

Vascular network quantification

Angiotool (NIH) software in Fiji (ImageJ, NIH) was used to quantify the vasculature formed in the cell-laden hydrogels. The fluorescence images of the GFP-HUVEC networks were processed through a sequence of steps including image segmentation, skeletonization, optimal thresholds for vessel diameter and signal strength, and removal of small particles. From this, various vessel morphometry parameters such as vessel percent area, total vessel length, average vessel length, and vascular branching index were calculated29.

Statistical analysis

All assays were performed for n = 3 replicates and data presented as mean ± standard deviation. Statistical analysis was conducted using two-way ANOVA followed by Tukey post hoc tests (a = 0.05) with Graphpad Prism 8.

Acknowledgements

We thank Dr. Anibal Diogenes (University of Texas) for providing the SCAP cells and Dr. Brian Johnstone, from OHSU Orthopedics for donating the BMSC. This project was supported by funding from the National Institute of Dental and Craniofacial Research (R01DE026170 and 3R01DE026170-03S1 to LEB).

Author contributions

S.P.P. analyzed all the data and wrote the manuscript. W.H., N.M., A.A., C.M.F. did the experiments and collected the data. L.E.B. conceptualized and designed the experiment and wrote the manuscript.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Chandra P, Atala A. Engineering blood vessels and vascularized tissues: technology trends and potential clinical applications. Clin. Sci. 2019;133:1115–1135. doi: 10.1042/cs20180155. [DOI] [PubMed] [Google Scholar]
  • 2.Bertassoni LE, et al. Direct-write bioprinting of cell-laden methacrylated gelatin hydrogels. Biofabrication. 2014;6:024105. doi: 10.1088/1758-5082/6/2/024105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bertassoni LE, et al. Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs. Lab. Chip. 2014;14:2202–2211. doi: 10.1039/c4lc00030g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zhao F, et al. Construction of a vascularized bladder with autologous adipose-derived stromal vascular fraction cells combined with bladder acellular matrix via tissue engineering. J. Tissue Eng. 2019;10:2041731419891256. doi: 10.1177/2041731419891256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Pill K, et al. Microvascular networks from endothelial cells and mesenchymal stromal cells from adipose tissue and bone marrow: a comparison. Front Bioeng. Biotechnol. 2018;6:156. doi: 10.3389/fbioe.2018.00156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ribatti D, Nico B, Crivellato E. Morphological and molecular aspects of physiological vascular morphogenesis. Angiogenesis. 2009;12:101–111. doi: 10.1007/s10456-008-9125-1. [DOI] [PubMed] [Google Scholar]
  • 7.Patel-Hett S, Damore PA. Signal transduction in vasculogenesis and developmental angiogenesis. Int. J. Dev. Biol. 2011;55:353–363. doi: 10.1387/ijdb.103213sp. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Laschke MW, et al. Insulin-like growth factor 1 stimulates the angiogenic activity of adipose tissue-derived microvascular fragments. J. Tissue Eng. 2019;10:2041731419879837. doi: 10.1177/2041731419879837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Eberth, C. J. Handbuch der Lehre von der Gewegen des Menschen und der Tiere, Vol 1 (1871).
  • 10.Rouget C. Memoire sur le develloppment, la structure et les propietes physiologiques des capillaries senguins et lymphatiques. Arch. Physiol. Norm. Pathol. 1873;5:603–663. [Google Scholar]
  • 11.Der Zimmermann KW. feinere Bau der Blutcapillaren. Zeitschrift für Anatomie und Entwicklungsgeschichte. 1923;68:29–109. doi: 10.1007/bf02593544. [DOI] [Google Scholar]
  • 12.Lindahl P. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997;277:242–245. doi: 10.1126/science.277.5323.242. [DOI] [PubMed] [Google Scholar]
  • 13.Goritz C, et al. A pericyte origin of spinal cord scar tissue. Science. 2011;333:238–242. doi: 10.1126/science.1203165. [DOI] [PubMed] [Google Scholar]
  • 14.Crisan M, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3:301–313. doi: 10.1016/j.stem.2008.07.003. [DOI] [PubMed] [Google Scholar]
  • 15.Hall CN, et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 2014;508:55–60. doi: 10.1038/nature13165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Proebstl D, et al. Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J. Exp. Med. 2012;209:1219–1234. doi: 10.1084/jem.20111622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood–brain barrier integrity during embryogenesis. Nature. 2010;468:562–566. doi: 10.1038/nature09513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Armulik A, et al. Pericytes regulate the blood–brain barrier. Nature. 2010;468:557–561. doi: 10.1038/nature09522. [DOI] [PubMed] [Google Scholar]
  • 19.Hartmann DA, et al. Pericyte structure and distribution in the cerebral cortex revealed by high-resolution imaging of transgenic mice. Neurophotonics. 2015 doi: 10.1117/1.NPh.2.4.041402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Strain WD, Paldánius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovascular Diabetology. 2018 doi: 10.1186/s12933-018-0703-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Corselli M, et al. The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev. 2012;21:1299–1308. doi: 10.1089/scd.2011.0200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Cheng L, et al. Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell. 2013;153:139–152. doi: 10.1016/j.cell.2013.02.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Duttenhoefer F, et al. 3D scaffolds co-seeded with human endothelial progenitor and mesenchymal stem cells: evidence of prevascularisation within 7 days. Eur. Cells Mater. 2013;26:59–65. doi: 10.22203/eCM.v026a04. [DOI] [PubMed] [Google Scholar]
  • 24.Stebbins MJ, et al. Human pluripotent stem cell-derived brain pericyte-like cells induce blood-brain barrier properties. Sci. Adv. 2019 doi: 10.1126/sciadv.aau7375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Xu J, Gong T, Heng BC, Zhang CF. A systematic review: differentiation of stem cells into functional pericytes. FASEB J. 2017;31:1775–1786. doi: 10.1096/fj.201600951RRR. [DOI] [PubMed] [Google Scholar]
  • 26.Pittenger MF, et al. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen. Med. 2019;4:22. doi: 10.1038/s41536-019-0083-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Xuan K, et al. Deciduous autologous tooth stem cells regenerate dental pulp after implantation into injured teeth. Sci. Transl. Med. 2018 doi: 10.1126/scitranslmed.aaf3227. [DOI] [PubMed] [Google Scholar]
  • 28.Kang J, Fan W, Deng Q, He H, Huang F. Stem cells from the apical papilla: a promising source for stem cell-based therapy. Biomed. Res. Int. 2019;2019:6104738. doi: 10.1155/2019/6104738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Monteiro N, He W, Franca CM, Athirasala A, Bertassoni LE. Engineering microvascular networks in LED light-cured cell-laden hydrogels. ACS Biomater. Sci. Eng. 2018;4:2563–2570. doi: 10.1021/acsbiomaterials.8b00502. [DOI] [PubMed] [Google Scholar]
  • 30.Liang Y, et al. Endothelial progenitors enhanced the osteogenic capacities of mesenchymal stem cells in vitro and in a rat alveolar bone defect model. Arch. Oral Biol. 2016;68:123–130. doi: 10.1016/j.archoralbio.2016.04.007. [DOI] [PubMed] [Google Scholar]
  • 31.Panduwawala CP, et al. In vivo periodontal tissue regeneration by periodontal ligament stem cells and endothelial cells in three-dimensional cell sheet constructs. J. Periodontal Res. 2017;52:408–418. doi: 10.1111/jre.12405. [DOI] [PubMed] [Google Scholar]
  • 32.Khayat A, et al. GelMA-encapsulated hDPSCs and HUVECs for dental pulp regeneration. J. Dent. Res. 2016;96:192–199. doi: 10.1177/0022034516682005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Levenberg S, et al. Engineering vascularized skeletal muscle tissue. Nat. Biotechnol. 2005;23:879–884. doi: 10.1038/nbt1109. [DOI] [PubMed] [Google Scholar]
  • 34.Thrivikraman G, et al. Rapid fabrication of vascularized and innervated cell-laden bone models with biomimetic intrafibrillar collagen mineralization. Nat. Commun. 2019 doi: 10.1038/s41467-019-11455-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Tsigkou O, et al. Engineered vascularized bone grafts. Proc. Natl. Acad. Sci. 2010;107:3311–3316. doi: 10.1073/pnas.0905445107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Xiong H, Chen K, Huang Y, Liu C. Human stem cells from apical papilla can regenerate dentin-pulp complex. Nan Fang Yi Ke Da Xue Xue Bao. 2013;33:1512–1516. [PubMed] [Google Scholar]
  • 37.Dissanayaka WL, Hargreaves KM, Jin L, Samaranayake LP, Zhang C. The interplay of dental pulp stem cells and endothelial cells in an injectable peptide hydrogel on angiogenesis and pulp regeneration in vivo. Tissue Eng Part A. 2015;21:550–563. doi: 10.1089/ten.TEA.2014.0154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Armulik A, Genové G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell. 2011;21:193–215. doi: 10.1016/j.devcel.2011.07.001. [DOI] [PubMed] [Google Scholar]
  • 39.Koike N, et al. Tissue engineering: creation of long-lasting blood vessels. Nature. 2004;428:138–139. doi: 10.1038/428138a. [DOI] [PubMed] [Google Scholar]
  • 40.Armulik A, Genove G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell. 2011;21:193–215. doi: 10.1016/j.devcel.2011.07.001. [DOI] [PubMed] [Google Scholar]
  • 41.Gaengel K, Genove G, Armulik A, Betsholtz C. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb. Vasc. Biol. 2009;29:630–638. doi: 10.1161/ATVBAHA.107.161521. [DOI] [PubMed] [Google Scholar]
  • 42.Loibl M, et al. Direct cell–cell contact between mesenchymal stem cells and endothelial progenitor cells induces a pericyte-like phenotype in vitro. Biomed. Res. Int. 2014;1–10:2014. doi: 10.1155/2014/395781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kurpinski K, et al. Transforming growth factor-β and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells. 2010;28:734–742. doi: 10.1002/stem.319. [DOI] [PubMed] [Google Scholar]
  • 44.Jakobsson L, van Meeteren LA. Transforming growth factor β family members in regulation of vascular function: in the light of vascular conditional knockouts. Exp. Cell Res. 2013;319:1264–1270. doi: 10.1016/j.yexcr.2013.02.015. [DOI] [PubMed] [Google Scholar]
  • 45.Hannan RL, et al. Endothelial cells synthesize basic fibroblast growth factor and transforming growth factor beta. Growth Factors. 2009;1:7–17. doi: 10.3109/08977198809000242. [DOI] [PubMed] [Google Scholar]
  • 46.Monteiro N, et al. Photopolymerization of cell-laden gelatin methacryloyl hydrogels using a dental curing light for regenerative dentistry. Dent. Mater. 2018;34:389–399. doi: 10.1016/j.dental.2017.11.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Athirasala A, et al. A novel strategy to engineer pre-vascularized full-length dental pulp-like tissue constructs. Sci. Rep. 2017 doi: 10.1038/s41598-017-02532-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.von Tell D, Armulik A, Betsholtz C. Pericytes and vascular stability. Exp. Cell Res. 2006;312:623–629. doi: 10.1016/j.yexcr.2005.10.019. [DOI] [PubMed] [Google Scholar]
  • 49.Joyce NC, Haire MF, Palade GE. Contractile proteins in pericytes. II. Immunocytochemical evidence for the presence of two isomyosins in graded concentrations. J. Cell Biol. 1985;100:1387–1395. doi: 10.1083/jcb.100.5.1387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Skalli O, et al. Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J. Histochem. Cytochem. 2017;37:315–321. doi: 10.1177/37.3.2918221. [DOI] [PubMed] [Google Scholar]
  • 51.Alimperti S, et al. Three-dimensional biomimetic vascular model reveals a RhoA, Rac1, and. Proc. Natl. Acad. Sci U. S. A. 2017;114:8758–8763. doi: 10.1073/pnas.1618333114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Holm A, Heumann T, Augustin HG. Microvascular mural cell organotypic heterogeneity and functional plasticity. Trends Cell Biol. 2018;28:302–316. doi: 10.1016/j.tcb.2017.12.002. [DOI] [PubMed] [Google Scholar]
  • 53.Ozerdem U, Grako KA, Dahlin-Huppe K, Monosov E, Stallcup WB. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev. Dyn. 2001;222:218–227. doi: 10.1002/dvdy.1200. [DOI] [PubMed] [Google Scholar]
  • 54.Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 2005;7:452–464. doi: 10.1215/S1152851705000232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Geevarghese A, Herman IM. Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies. Transl. Res. 2014;163:296–306. doi: 10.1016/j.trsl.2014.01.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Crisan M, et al. Perivascular multipotent progenitor cells in human organs. Ann. N. Y. Acad. Sci. 2009;1176:118–123. doi: 10.1111/j.1749-6632.2009.04967.x. [DOI] [PubMed] [Google Scholar]
  • 57.Bandopadhyay R, et al. Contractile proteins in pericytes at the blood-brain and blood-retinal barriers. J. Neurocytol. 2001;30:35–44. doi: 10.1023/a:1011965307612. [DOI] [PubMed] [Google Scholar]
  • 58.Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 2000;97:13625–13630. doi: 10.1073/pnas.240309797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.França CM, et al. 3D-imaging of whole neuronal and vascular networks of the human dental pulp via CLARITY and light sheet microscopy. Sci. Rep. 2019 doi: 10.1038/s41598-019-47221-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Nichol JW, et al. Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials. 2010;31:5536–5544. doi: 10.1016/j.biomaterials.2010.03.064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Athirasala A, et al. A novel strategy to engineer pre-vascularized full-length dental pulp-like tissue constructs. Sci. Rep. 2017;7:3323. doi: 10.1038/s41598-017-02532-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Monteiro N, et al. Photopolymerization of cell-laden gelatin methacryloyl hydrogels using a dental curing light for regenerative dentistry. Dent Mater. 2018;34:389–399. doi: 10.1016/j.dental.2017.11.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Monteiro, N., He, W., Franca, C., Athirasala, A. & Bertassoni, L. Engineering microvascular networks in LED light-cured cell-laden hydrogels. ACS Biomater. Sci. Eng. (in press) (2018). [DOI] [PubMed]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES